Since the development and approval of new direct-acting antiviral (DAA) drugs, chronic hepatitis C virus (HCV) infection is now considered a curable disease. However, the emphasis on DAA therapies might disregard other preventive meas-ures, and limits the strategy for a clinical cure rather than comprehensive disease control. The Qatar National plan for HCV control was launched in December 2014 to prioritize and proactively manage HCV with the ultimate aim of elim-inating viral hepatitis. The plan is based on four pillars: primary prevention, early detection, clinical management, and continuous monitoring. This report describes the activities undertaken in Qatar to prepare for the programme and the early results of its initial phase, given the fact that countries with comprehensive HCV plans are providing better access to care and prevention.
CITATION STYLE
Derbala, M., Farag, E. A., Al-Romaihi, H., Al Kaabi, S., Al-Thani, M., El Sayed, E., … Himatt, S. (2019). An overview of the hepatitis c control plan in qatar. Eastern Mediterranean Health Journal, 25(5), 363–365. https://doi.org/10.26719/emhj.18.046
Mendeley helps you to discover research relevant for your work.